NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that Mr. Thomas Klein, Pluristem’s EU representative, will present at the conference of the Society of Investment Professionals in Germany, the DVFA, on “The Placenta, from the Miracle of Birth to Therapeutics to All”. This is the second annual Life Science Conference for the DVFA and Pluristem will present on Tuesday, June 16, 2009 at the DVFA Center, Frankfurt, Germany.
